Mouse anti-Phospho-AKT1 ( Ser473 ) Monoclonal Antibody

Mouse anti-Phospho-AKT1 ( Ser473 ) Monoclonal Antibody

Catalog Number:
A001079863RED
Mfr. No.:
RD86450A
Price:
$253
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          The serine-threonine protein kinase AKT1 is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery.

      • Properties
        • Host
          mouse
          Antibody Type
          monoclonal
          Isotype
          IgG
          Reactivity
          human
          Immunogen
          Synthetic Peptide of Phospho-Akt (S473)
          Purification
          Protein A purification
          Conjugate
          Unconjugated
          Formulation
          PBS with 0.02% sodium azide,0.5% BSA and 50% glycerol pH 7.4.
          Storage
          Store at -20°C. Avoid repeated freeze / thaw cycles.
          Concentration
          1mg/mL
          Antigen
          AKT 1; AKT; AKT1; AKT1; MGC99656; PKB; PKB-ALPHA; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha (Gene ID:207; UniProt:P31749)

          * For research use only.

      • Applications
        • Application
          WB; IHC (paraffin)

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.